Cargando…

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker

OBJECTIVE: Neuropathological studies in amyotrophic lateral sclerosis (ALS) have shown a dissemination in a regional sequence in four anatomically defined patterns. The aim of this retrospective study was to see whether longitudinal diffusion tensor imaging (DTI) data support the pathological findin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassubek, Jan, Müller, Hans-Peter, Del Tredici, Kelly, Lulé, Dorothée, Gorges, Martin, Braak, Heiko, Ludolph, Albert C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869447/
https://www.ncbi.nlm.nih.gov/pubmed/29101254
http://dx.doi.org/10.1136/jnnp-2017-316365
_version_ 1783309289316679680
author Kassubek, Jan
Müller, Hans-Peter
Del Tredici, Kelly
Lulé, Dorothée
Gorges, Martin
Braak, Heiko
Ludolph, Albert C
author_facet Kassubek, Jan
Müller, Hans-Peter
Del Tredici, Kelly
Lulé, Dorothée
Gorges, Martin
Braak, Heiko
Ludolph, Albert C
author_sort Kassubek, Jan
collection PubMed
description OBJECTIVE: Neuropathological studies in amyotrophic lateral sclerosis (ALS) have shown a dissemination in a regional sequence in four anatomically defined patterns. The aim of this retrospective study was to see whether longitudinal diffusion tensor imaging (DTI) data support the pathological findings. METHODS: The application of DTI analysis to fibre structures that are prone to be involved at each neuropathological pattern of ALS was performed in a monocentre sample of 67 patients with ALS and 31 controls that obtained at least one follow-up scan after a median of 6 months. RESULTS: At the group level, longitudinal ALS data showed significant differences for the stage-related tract systems. At the individual level, 27% of the longitudinally scanned patients with ALS showed an increase in ALS stage, while the remaining were stable or were at the highest ALS stage. Longitudinal fractional anisotropy changes in the respective tract systems correlated significantly with the slope of the revised ALS functional rating scale. INTERPRETATION: The DTI-based protocol was able to image the disease patterns of ALS in vivo cross-sectionally and longitudinally, in support of DTI as a technical marker to image ALS stages.
format Online
Article
Text
id pubmed-5869447
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58694472018-03-28 Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker Kassubek, Jan Müller, Hans-Peter Del Tredici, Kelly Lulé, Dorothée Gorges, Martin Braak, Heiko Ludolph, Albert C J Neurol Neurosurg Psychiatry Neurodegeneration OBJECTIVE: Neuropathological studies in amyotrophic lateral sclerosis (ALS) have shown a dissemination in a regional sequence in four anatomically defined patterns. The aim of this retrospective study was to see whether longitudinal diffusion tensor imaging (DTI) data support the pathological findings. METHODS: The application of DTI analysis to fibre structures that are prone to be involved at each neuropathological pattern of ALS was performed in a monocentre sample of 67 patients with ALS and 31 controls that obtained at least one follow-up scan after a median of 6 months. RESULTS: At the group level, longitudinal ALS data showed significant differences for the stage-related tract systems. At the individual level, 27% of the longitudinally scanned patients with ALS showed an increase in ALS stage, while the remaining were stable or were at the highest ALS stage. Longitudinal fractional anisotropy changes in the respective tract systems correlated significantly with the slope of the revised ALS functional rating scale. INTERPRETATION: The DTI-based protocol was able to image the disease patterns of ALS in vivo cross-sectionally and longitudinally, in support of DTI as a technical marker to image ALS stages. BMJ Publishing Group 2018-04 2017-11-03 /pmc/articles/PMC5869447/ /pubmed/29101254 http://dx.doi.org/10.1136/jnnp-2017-316365 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Neurodegeneration
Kassubek, Jan
Müller, Hans-Peter
Del Tredici, Kelly
Lulé, Dorothée
Gorges, Martin
Braak, Heiko
Ludolph, Albert C
Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
title Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
title_full Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
title_fullStr Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
title_full_unstemmed Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
title_short Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
title_sort imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
topic Neurodegeneration
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869447/
https://www.ncbi.nlm.nih.gov/pubmed/29101254
http://dx.doi.org/10.1136/jnnp-2017-316365
work_keys_str_mv AT kassubekjan imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker
AT mullerhanspeter imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker
AT deltredicikelly imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker
AT luledorothee imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker
AT gorgesmartin imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker
AT braakheiko imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker
AT ludolphalbertc imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker